Home » Newsletters » BioWorld Science

BioWorld Science

May 16, 2001

View Archived Issues

NIH licensing opportunity: detection and quantification of CR1 in human milk using ELISA

NIH licensing opportunity: identification of new small bacterial RNAs

Durect acquires Southern BioSystems

Rituximab filed in E.U., approved in U.S. for expanded indications

FDA advisory committee to review NDA for first-in-class antidiabetic therapy

First combination hepatitis A & B vaccine approved by FDA

Centaur's CPI-1189 shows efficacy in phase IIa trials in patients with dementia

Crucell and UMC Utrecht enter alliance for type 2 diabetes therapeutics

Phase II liver cancer trial of Zadaxin/TACE announced

Manzamine alkaloids from deep-sea sponge show potent antiinfective activity

Anticonvulsant agents reduce trigeminal nerve-induced neurovascular reflexes

Progenics reacquires rights to cancer vaccines; phase III trial in melanoma begins

First-quarter 2001 highlights and product update presented by NPS

AltaRex presents encouraging results from phase I BrevaRex MAb trial

Long-term safety and efficacy of adalimumab demonstrated in active RA

Company Profile: Hormos Medical

NDA filed in Hong Kong for NexMed's ED treatment

Humanized antibody safe and effective in phase I/II studies in RA patients

Several ARVO presentations cover preclinical and early clinical profile of AL-6598

AGI Dermatics reports promising results with skin cancer prevention drug

Company Profile: OPi

Cor patents new series of factor Xa inhibitors with high potency and selectivity

New indole-based sPLA2 inhibitors in development at Lilly

AstraZeneca identifies quinazoline derivatives as inhibitors of aurora2 kinase

Preparation and use of calcium channel antagonist series described by Ortho-McNeil

Small molecules from Genentech inhibit interaction between alpha4 integrins and their ligands

Meiji Seika's new phosphonic acid derivatives particularly useful in thrombotic disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...